Riociguat for the treatment of pulmonary arterial hypertension (PAH): 2-year results from the PATENT-2 long-term extension

Authors
Category Primary study
JournalEuropean Respiratory Journal
Year 2014
This article has no abstract
Epistemonikos ID: 5e5d1bc545b583cb4771696a5805fe5df5d5eebd
First added on: Feb 07, 2025